Back to Trades
Steinhart Richard I
DirectorCIK 0001293789
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 10
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 3
- Active
- 2025–2026
Steinhart Richard I, Director, accounts for 10 disclosed filings worth $101.6K, spread across 3 companies, active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $7.4K in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
10 loaded
| Sep 4 | ATNM Actinium Pharmaceuticals, Inc. | Steinhart Richard I | Director | Grant | $94.2K |
| Jun 17 | BTAI BioXcel Therapeutics, Inc. | Steinhart Richard I | Chief Financial Officer | Exercise | $0 |
| May 22 | BTAI BioXcel Therapeutics, Inc. | Steinhart Richard I | Chief Financial Officer | Sell | $7.4K |
| May 14 | ATOS ATOSSA THERAPEUTICS, INC. | Steinhart Richard I | Insider | Grant | $0 |
| May 7 | BTAI BioXcel Therapeutics, Inc. | Steinhart Richard I | Chief Financial Officer | Exercise | $0 |
| Jan 5 | BTAI BioXcel Therapeutics, Inc. | Steinhart Richard I | Chief Financial Officer | Award | $0 |
| Dec 15 | BTAI BioXcel Therapeutics, Inc. | Steinhart Richard I | Chief Financial Officer | Exercise | $0 |
| Sep 16 | BTAI BioXcel Therapeutics, Inc. | Steinhart Richard I | Chief Financial Officer | Exercise | $0 |
| Aug 5 | BTAI BioXcel Therapeutics, Inc. | Steinhart Richard I | Chief Financial Officer | Award | $0 |
| Jul 22 | BTAI BioXcel Therapeutics, Inc. | Steinhart Richard I | Chief Financial Officer | Grant | $0 |
10 filings